1. Home
  2. CMPR vs WVE Comparison

CMPR vs WVE Comparison

Compare CMPR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPR
  • WVE
  • Stock Information
  • Founded
  • CMPR 1994
  • WVE 2012
  • Country
  • CMPR Ireland
  • WVE Singapore
  • Employees
  • CMPR N/A
  • WVE 268
  • Industry
  • CMPR Publishing
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMPR Consumer Discretionary
  • WVE Health Care
  • Exchange
  • CMPR Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CMPR 2.0B
  • WVE 1.7B
  • IPO Year
  • CMPR N/A
  • WVE 2015
  • Fundamental
  • Price
  • CMPR $49.75
  • WVE $11.13
  • Analyst Decision
  • CMPR Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • CMPR 2
  • WVE 10
  • Target Price
  • CMPR $91.00
  • WVE $21.60
  • AVG Volume (30 Days)
  • CMPR 220.9K
  • WVE 734.1K
  • Earning Date
  • CMPR 01-29-2025
  • WVE 03-05-2025
  • Dividend Yield
  • CMPR N/A
  • WVE N/A
  • EPS Growth
  • CMPR 281.41
  • WVE N/A
  • EPS
  • CMPR 6.02
  • WVE N/A
  • Revenue
  • CMPR $3,357,327,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • CMPR $5.20
  • WVE N/A
  • Revenue Next Year
  • CMPR $4.13
  • WVE $48.58
  • P/E Ratio
  • CMPR $8.31
  • WVE N/A
  • Revenue Growth
  • CMPR 4.60
  • WVE N/A
  • 52 Week Low
  • CMPR $47.83
  • WVE $4.01
  • 52 Week High
  • CMPR $104.92
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CMPR 24.52
  • WVE 44.53
  • Support Level
  • CMPR $47.83
  • WVE $10.79
  • Resistance Level
  • CMPR $53.85
  • WVE $11.78
  • Average True Range (ATR)
  • CMPR 2.47
  • WVE 0.69
  • MACD
  • CMPR -0.70
  • WVE 0.05
  • Stochastic Oscillator
  • CMPR 11.39
  • WVE 43.95

About CMPR Cimpress plc (Ireland)

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: